Literature DB >> 8094491

Persistent hepatitis C viraemia without liver disease.

S Brillanti1, M Foli, S Gaiani, C Masci, M Miglioli, L Barbara.   

Abstract

In viral infections persistence of the virus is not always associated with virus-induced disease. To find out if active hepatitis C virus (HCV) infection can persist without liver disease we selected four symptom-free individuals with antibodies to HCV but normal aminotransferase levels. They were followed up for 3 years by monthly serology and a liver biopsy was done. At presentation, all four had both antibodies to HCV and circulating HCV RNA. During follow-up their sera remained persistently positive for all HCV antibodies and RNA yet aminotransferase levels did not increase and liver biopsy was normal. These findings indicate that persistent hepatitis C viraemia is not invariably associated with liver damage.

Entities:  

Mesh:

Year:  1993        PMID: 8094491     DOI: 10.1016/0140-6736(93)90210-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  Hepatitis C: Recent advances.

Authors:  S D Shafran; J M Conly
Journal:  Can J Infect Dis       Date:  1993-07

2.  Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

Authors:  G Missale; R Bertoni; V Lamonaca; A Valli; M Massari; C Mori; M G Rumi; M Houghton; F Fiaccadori; C Ferrari
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  sPECAM-1 and sVCAM-1: Role in Pathogenesis and Diagnosis of Chronic Hepatitis C and Association with Response to Antiviral Therapy.

Authors:  Michal Kukla; Krystyna Zwirska-Korczala; Andrzej Gabriel; Ewa Janczewska-Kazek; Agnieszka Berdowska; Andrzej Wiczkowski; Barbara Rybus-Kalinowska; Mariusz Kalinowski; Adam Ziolkowski; Elzbieta Wozniak-Grygiel; Marek Waluga; Blazej Nowak
Journal:  Therap Adv Gastroenterol       Date:  2009-03       Impact factor: 4.409

Review 4.  Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment.

Authors:  J Hayashi; S Kashiwagi
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

5.  Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs.

Authors:  M G Ghany; C Leissinger; R Lagier; R Sanchez-Pescador; A S Lok
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

6.  A comparison between previous and present histologic assessments of chronic hepatitis C viral infections in humans.

Authors:  N Assy; GY Minuk
Journal:  World J Gastroenterol       Date:  1999-04       Impact factor: 5.742

Review 7.  Hepatitis C: diagnosis and treatment.

Authors:  I Scotiniotis; C A Brass; P F Malet
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

Review 8.  Histopathology and detection of hepatitis C virus in liver.

Authors:  P J Scheuer; K Krawczynski; A P Dhillon
Journal:  Springer Semin Immunopathol       Date:  1997

9.  Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases.

Authors:  G Montalto; A L Zignego; M I Ruggeri; C Giannini; M Soresi; M Monti; A Carroccio; G Careccia; D Di Martino; F Giannelli
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

10.  Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease.

Authors:  C M da Silva; F L David; M N Muscará; S S Sousa; J G Ferraz; G de Nucci; N C Polimeno; J Pedrazzoli
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.